| 摘要 |
The invention relates to novel compounds of formula (I) wherein R<1>, R<2>, R<3>, R<4>, X and Y have the meaning given in Claim 1. Said compounds are inhibitors of the coagulation factor Xa and can be used for the prophylaxis and/or therapy of thrombo-embolic diseases. |
